期刊文献+

甲胎蛋白阴性的小肝占位病例的诊治经验 被引量:2

Experience in diagnosis and treatment for small hepatic lesions with negative serum alpha-fetoprotein
下载PDF
导出
摘要 目的直径<2cm的肝脏占位通常不具备典型的肝脏肿瘤影像学特点,当甲胎蛋白化验结果阴性时诊断尤其困难,通过对这部分病例诊治过程和随诊结果的回顾和分析,总结甲胎蛋白阴性的小肝占位病例的诊治经验。方法我科2003年1月~2008年12月共收治103例直径≤2cm且甲胎蛋白阴性的肝脏占位病例,根据肿瘤多发性选择数字减影血管成像(DSA)、动态增强磁共振成像(MRI)、造影超声或PET-CT进行鉴别诊断,对于疑诊的94例病例行部分肝切除术。结果这四种检查手段对肝脏恶性肿瘤的诊断准确率分别为88.2%、93.9%、88.9%和88.9%;本组手术病例手术并发症率低(6.4%)、预后良好,肝癌病例的1年生存率和3年生存率分别为98.8%和76.1%。结论 DSA、动态增强MRI、造影超声和PET-CT检查对于小肝占位均有很好的诊断价值;手术方式宜采取肝脏部分切除术;小肝癌病例手术风险小、预后好,对于疑诊病例应积极进行手术治疗。 Objective To summarize our experiences in diagnosis and management of small hepatic lesions with negative alpha- fetoprotein (AFP). Methods Totally 103 patients with hepatic small lesions (2cm and of negative serum AFP were enrolled from our department during the past six years. For differential diagnosis, digital subtraction angiography ( DSA), dynamic contrast - enhanced magnetic resonance imaging ( MRI), contrasted ultrasonography, or positive emission tomography - computed tomography ( PET - CT) was selected, according to whether tumors occurred singly or were multiple. Liver resection was performed in 94 patients suspected of cancer. Results The diagnostic accuracy of the four procedures in defining the malignancies of hepatic masses was 88.2% , 93.9% , 88. 9% , and 88.9% , respectively. The patients who' had undergone surgeries experienced a low incidence of complications (6.4%) , and good prognosis, 'with 1 - and 3 - year survival of 98. 8% and 76. 1%, respectively. Conclusions DSA, dynamic contrast - enhanced MRI, contrasted ultrasonography, and PET - CT are all valuable in the diagnosis of small hepatic lesions. Partial liver resection, with low risk and favorable prognosis, is recommended.
出处 《癌症进展》 2010年第3期285-289,共5页 Oncology Progress
基金 美国China Medical Board of New York基金资助(项目编号:CMB 06-837)
关键词 肝脏占位 造影超声 动态增强核磁 PET—CT 肝切除术 hepatic lesion (s) contrasted ultrasonography dynamic contrast - enhanced magnetic resonance imagingPET - CT hepatectomy
  • 相关文献

参考文献4

二级参考文献18

  • 1徐智章,蒋天安,王文平,刘利民,颜志平,程浩敏,曾维新.二氧化碳肝动脉超声造影和常规超声在检出原发性肝癌灶中的对比研究[J].中华超声影像学杂志,1995,4(2):49-52. 被引量:9
  • 2霍力,周前,吴战宏,肖河,卢朝辉,李汉忠.^(11)C-乙酸盐PET显像在肾脏肿瘤诊断中的作用[J].中华核医学杂志,2006,26(4):205-208. 被引量:20
  • 3Cassandra Willyard. Researchers look for ‘sweet' method to diagnose cancer. Nat Med, 2007, 13: 1267.
  • 4Kladney RD, Bulla GA, Guo L, et al. GP73, a novel golgilocalized protein upregulated by viral infection. Gene, 2000, 249 : 53-65.
  • 5Kladney RD, Cui X, Bulla GA, et al. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology, 2002, 35 : 1431-1440.
  • 6Marrero JA, Romano PR, Nikolaeva O, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol, 2005, 43: 1007-1012.
  • 7林礼务.临床B型超声显像诊断[M].福州:福建科学技术出版社,1985.427-429.
  • 8林贵 顾晋 王述祥.肝占位性病变的肝动脉造影和影像学诊断[M].上海:上海科学技术出版社,1992.127-129.
  • 9Kim YJ,Yun M,Lee WJ,et al.Usefulness of (18)F-FDG PET in intrahepatic cholangiocarcinoma[J].Eur J Nucl Med Mol Imaging,2003,30(11):1467-1472.
  • 10Ho CL,Yu SC,Yeung DW,et al.11C-acetate PET imaging in hepatocellular carcinoma and other liver masses[J].J Nucl Med,2003,44(2):213-221.

共引文献159

同被引文献17

  • 1孙鋆泽,陆华虎,吕凌,张峰.影响肝癌术后复发危险因素的研究进展[J].中华临床医师杂志(电子版),2011,5(11):3245-3249. 被引量:8
  • 2王荣福.多模态影像技术在肿瘤诊治中的应用进展[J].肿瘤影像学,2013,22(4):292-295. 被引量:10
  • 3Lu X,Zhao H,Yang H. A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy[J].Journal of Surgical Oncology,2009.488-493.
  • 4Chen WT,Chau GY,Lui WY. Recurrent hepatocellular carcinoma after hepatic resection:prognostic factors and long-term outcome[J].European Journal of Surgical Oncology,2004.414-420.
  • 5Nakashima O,Kojiro M. Recurrence of hepatocellular carcinoma:multicentric occurrence or intrahepatic metastasis. A viewpoint in terms of pathology[J].Journal of Hepato-Biliary-Pancreatic Surgery,2001.404-409.
  • 6Chan AC,Poon RT,Cheung TT. Survival Analysis of Re-resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma[J].World Journal of Surgery,2012.151-156.
  • 7中国抗癌协会肝癌专业委员会.原发性肝癌规范化诊治专家共识[J]临床肿瘤学杂志,2009259-269.
  • 8Choi JW,Park JY,Ahn SH. Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection[J].American Journal of Clinical Oncology,2009.564-569.
  • 9李肖,唐承薇.原发性肝癌的诊断和治疗[J].中华临床医师杂志(电子版),2009,3(10):4-7. 被引量:22
  • 10方敏,彭春伟,刘少平,袁静萍,李雁.In Vitro Invasive Pattern of Hepatocellular Carcinoma Cell Line HCCLM9 Based on Three-dimensional Cell Culture and Quantum Dots Molecular Imaging[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2013,33(4):520-524. 被引量:7

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部